Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

BACKGROUND: The efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer has been demonstrated in phase III trials. However, as patients receiving eribulin in daily practice do not necessarily meet all the eligibility criteria of clinical trials, data for such pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Iizumi, Sakura, Shimoi, Tatsunori, Tsushita, Natsuko, Bun, Seiko, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716387/
https://www.ncbi.nlm.nih.gov/pubmed/29202787
http://dx.doi.org/10.1186/s12885-017-3846-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716387/
https://www.ncbi.nlm.nih.gov/pubmed/29202787
http://dx.doi.org/10.1186/s12885-017-3846-8

Ejemplares similares